IL-27 inhibited tumor growth of melanomas, while anti-TRAIL Ab, but not control Ab, partly but significantly abrogated the inhibitory effect by IL-27 on tumor growth in all three melanoma cell lines (Fig. 1E). Here, TNFSF10 is linked to neoplasm.